Gene · 92521
Papers3,158
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,781 to 1,800 of 3,158
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| COVID-19 and liver disease: mechanistic and clinical perspectives. | Nat Rev Gastroenterol Hepatol | 2021 | 33692570 | PubTator, text mining | PubMed |
| Drug design and repurposing with DockThor-VS web server focusing on SARS-CoV-2 therapeutic targets and their non-synonym variants. | Sci Rep | 2021 | 33692377 | PubTator, text mining | PubMed |
| The in-vitro effect of famotidine on sars-cov-2 proteases and virus replication. | Sci Rep | 2021 | 33686143 | PubTator, text mining | PubMed |
| An immune epigenetic insight to COVID-19 infection. | Epigenomics | 2021 | 33685230 | PubTator, text mining | PubMed |
| Rotavirus Induces Epithelial-Mesenchymal Transition Markers by Transcriptional Suppression of miRNA-29b. | Front Microbiol | 2021 | 33679655 | PubTator, text mining | PubMed |
| Resveratrol Inhibits HCoV-229E and SARS-CoV-2 Coronavirus Replication In Vitro. | Viruses | 2021 | 33672333 | PubTator, text mining | PubMed |
| Structure-Based Identification of Natural Products as SARS-CoV-2 Mpro Antagonist from Echinacea angustifolia Using Computational Approaches. | Viruses | 2021 | 33672054 | PubTator, text mining | PubMed |
| Novel RT-ddPCR assays for simultaneous quantification of multiple noncoding and coding regions of SARS-CoV-2 RNA. | J Virol Methods | 2021 | 33667568 | PubTator, text mining | PubMed |
| Lessons learned 1 year after SARS-CoV-2 emergence leading to COVID-19 pandemic. | Emerg Microbes Infect | 2021 | 33666147 | PubTator, text mining | PubMed |
| SARS-CoV-2: Insights into its structural intricacies and functional aspects for drug and vaccine development. | Int J Biol Macromol | 2021 | 33662418 | PubTator, text mining | PubMed |
| Integration of transcriptome analysis with pathophysiological endpoints to evaluate cigarette smoke toxicity in an in vitro human airway tissue model. | Arch Toxicol | 2021 | 33660061 | PubTator, text mining | PubMed |
| Hallmarks of Alpha- and Betacoronavirus non-structural protein 7+8 complexes. | Sci Adv | 2021 | 33658206 | PubTator, text mining | PubMed |
| SARS-CoV-2 Nonstructural Proteins 1 and 13 Suppress Caspase-1 and the NLRP3 Inflammasome Activation. | Microorganisms | 2021 | 33652815 | PubTator, text mining | PubMed |
| Screening of drug databank against WT and mutant main protease of SARS-CoV-2: Towards finding potential compound for repurposing against COVID-19. | Saudi J Biol Sci | 2021 | 33649700 | PubTator, text mining | PubMed |
| Latest updates on SARS-CoV-2 genomic characterization, drug, and vaccine development; a comprehensive bioinformatics review. | Microb Pathog | 2021 | 33647446 | PubTator, text mining | PubMed |
| Novel Development of Predictive Feature Fingerprints to Identify Chemistry-Based Features for the Effective Drug Design of SARS-CoV-2 Target Antagonists and Inhibitors Using Machine Learning. | ACS Omega | 2021 | 33644594 | PubTator, text mining | PubMed |
| Cordifolioside: potent inhibitor against Mpro of SARS-CoV-2 and immunomodulatory through human TGF-β and TNF-α. | 3 Biotech | 2021 | 33643762 | PubTator, text mining | PubMed |
| Brief review on repurposed drugs and vaccines for possible treatment of COVID-19. | Eur J Pharmacol | 2021 | 33639193 | PubTator, text mining | PubMed |
| SARS-CoV-2 nsp12 attenuates type I interferon production by inhibiting IRF3 nuclear translocation. | Cell Mol Immunol | 2021 | 33637958 | PubTator, text mining | PubMed |
| RETRACTED: Inhibition of anti-viral stress granule formation by coronavirus endoribonuclease nsp15 ensures efficient virus replication. | PLoS Pathog | 2021 | 33635931 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/92521/papers?page=90